A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA

Sociology of Health and Illness

Volumn 34, Issue 2, 2012, Pages 234-250

  Hogarth, Stuart ^a   Hopkins, Michael M ^b   Rodriguez, Victor ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Entrenchment; Gene patents; Human papillomavirus; Innovation; Molecularisation; Screening

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; EARLY DIAGNOSIS; FEMALE; GENETIC SCREENING; HUMAN; INSTRUMENTATION; MASS COMMUNICATION; METHODOLOGY; PAPILLOMAVIRUS INFECTION; PATHOLOGY; UNITED STATES; UTERINE CERVIX TUMOR; VAGINA SMEAR;

DIFFUSION OF INNOVATION; EARLY DETECTION OF CANCER; FEMALE; GENETIC TESTING; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84857504722     PISSN: 01419889     EISSN: 14679566     Source Type: Journal    
DOI: 10.1111/j.1467-9566.2011.01411.x     Document Type: Article

References (45)

1. Amsterdamska, O. and Hiddinga, A. (2003) The analyzed body. In Cooter, R and Pickstone, J. (eds) Companion to Medicine in the Twentieth Century. London: Routledge.
2. Baker, M. (2006) New Wave diagnostics, Nature Biotechnology, 24, 8, 931-8.
3. Bijker, W.E. (1995) Of Bicycles, Bakelites and Bulbs: Towards a Theory of Sociotechnical Change. Cambridge: MIT Press.
4. Blume, S. (1992) Insight and Industry: on the Dynamics of Technological Change in Medicine. Cambridge: MIT Press.
5. Borgert, N. (2006) Testing providers work to improve cervical cancer diagnostics, Clinical Lab Products, available at (last accessed 18 September 2011).
6. Bowker, G. and Star, S. (1999) Sorting Things Out: Classification and its Consequences. Cambridge: MIT press.
7. Callon, M. (1986) Elements of a sociology of translation: domestication of the scallops and the fishermen of St Brieuc Bay. In Law, J. (ed.) Power, Action and Belief: a New Sociology of Knowledge? London: Routledge.
8. Casper, M. and Clarke, E. (1998) Making the Pap smear into the 'right tool' for the job: cervical cancer screening in the USA, circa 1940-1995, Social Studies of Science, 28, 2-3, 255-90.
9. de Chadarevian, S. and Kamminga, H. (eds) (1998) Molecularizing Biology and Medicine: New Practices and Alliances, 1910s-1970s. Amsterdam: Harwood.
10. Christensen, C.M., Grossman, J.H. and Hwang, J. (2009) The Innovator's Prescription. New York: McGraw Hill.
11. Clarke, A.E., Shim, J.K., Mamo, L., Fosket, J.R., et al. (2003) Biomedicalization: technoscientific transformation of health, illness, and US biomedicine, American Sociological Review, 682161-94.
12. Cox, T. and Cuzick, J. (2006) HPV DNA testing in cervical cancer screening: from evidence to policies, Gynecologic Oncology, 103, 1, 8-11.
13. Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., et al. (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study, The Lancet, 362, 9399, 1871-76.
14. Dehn, D., Torkko, K.C. and Shroyer, K.R. (2007) Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma, Cancer, 111, 1, 1-14.
15. Digene (2002) Annual Report, available at (last accessed 18 September 2011).
16. Edgerton, D. (2006) The Shock of the Old: Technology and Global History since 1900. London: Profile Books.
17. Fleck, J. (2000) Artefact-activity: the co-evolution of artefacts, knowledge and organisation in technological innovation. In Ziman, J. (ed.) Technology as an Evolutionary Process. Oxford: Oxford University Press.
18. Gelijns, A. and Rosenberg, N. (1994) The dynamics of technological change in medicine, Health Affairs, 13, 3, 28-46.
19. Hogarth, S. (2007) The Clinical Application of Molecular Diagnostic Technologies - a Review of the Regulatory and Policy Issues. Report for Health Canada. Cambridge: University of Cambridge.
20. Hopkins, M. (2004) Technique-led technological change and the hidden research system: genetic testing services in the NHS. PhD thesis, SPRU, University of Sussex.
21. Hopkins, M. (2006) The hidden research system: the evolution of cytogenetic testing in the National Health Service, Science as Culture, 15, 3, 253-76.
22. Hopkins, M., Martin, P., Nightingale, P., Kraft, A., et al. (2007) The myth of the biotech revolution: an assessment of technological, clinical and organisational change, Research Policy, 36, 4, 566-89.
23. Hughes, J. (1997). Whigs, prigs, and politics: problems in the historiography of contemporary science. In Soderqvest, T. (ed.) The Historiography of Science and Technology. Amsterdam, Harwood.
24. Hunt, D., Nguyen, L. and Rodgers, M. (2007) Patent Searching; Tools & Techniques. Hoboken: John Wiley and Sons.
25. Keating, P. and Cambrosio, A. (2003) Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge: MIT Press.
26. Koch, L. and Stemerding, D. (1994) The sociology of entrenchment: a cystic fibrosis test for everyone, Social Science & Medicine, 39, 9, 1211-20.
27. Levenson, D. (2007) New HPV test brings challenges, Clinical Laboratory News, 3361.
28. Lorincz, A.T., Reid, R., Bennett Jenson, A., Greenberg, M.D., et al. (1992) Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types, Obstetrics and Gynecology, 79, 3, 328-37.
29. Marshall Austin, R. (2008) Dismantling of the U.S. cytotechnology educational infrastructure is premature and carries significant risks, Archives of Pathology & Laboratory Medicine, 132, 2, 154-158.
30. Martin, P. (1999) Genes as drugs: the social shaping of genetherapy and the reconstruction of genetic disease, Sociology of Health & Illness, 21, 5, 517-38.
31. Moriarty, A., Schwartz, M.R., Eversole, G., Means, M., et al. (2008) Human papillomavirus testing and reporting rates: practices of participants in CAP's interlaboratory comparison program in gynecologic cytology in 2006, Archives of Pathology & Laboratory Medicine, 132, 8, 1290-4.
32. Parthasarathy, S. (2007) Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care. Cambridge: MIT Press.
33. Rajan, K (2006) Biocapital: the Constitution of Postgenomic Life. Durham, NC: Duke University Press.
34. Reynolds, L.A. and Tansey, E.M. (eds) (2009) History of Cervical Cancer and the Role of the Human Papillomavirus, 1960-2000, Wellcome Trust Witness Seminar Series. GC/253/A/38. London: University College London.
35. Rose, N. (2007) The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century. Princeton: Princeton University Press.
36. Rosenwald, M. (2005) Digene's ads take their case to women, Washington Post, 21 March, accessed online at.
37. Secretary's Advisory Committee on Genetics Health and Society, National Institutes of Health (2010) Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. Washington: SACGH.
38. Southwick, K. (2004) Kaiser roll: the push for more HPV screening, CAP Today, July.
39. Stoler, M. (2001) HPV for cervical cancer screening: is the era of the molecular Pap smear upon us? Journal of Histochemistry and Cytochemistry, 49, 9, 1197-8.
40. Stoler, M. (2002) New Bethesda terminology and evidence-based management for cervical cytology findings JAMA, 287, 16, 2140-1.
41. Timmermans, S. and Berg, M. (2003) The Gold Standard. Philadelphia: Temple University Press.
42. Titus, K. (2005) Making a valid point about HPV tests, CAP Today, September.
43. Van de Ven, A.H. (2007) Engaged Scholarship. Oxford: Oxford University Press.
44. Wright, T., Cox, J.T., Massad, L.S., Twiggs, L.B., et al. (2002) 2001 consensus guidelines for the management of women with cervical cytological abnormalities, JAMA, 287, 16, 2120-9.
45. Wright, T., Massad, L.S., Dunton, C.J., Spitzer, M., et al. (2007) 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests, American Journal of Obstetrics & Gynecology, 197, 4, 346-55.